Premium
Reports of adverse health effects related to synthetic cannabinoid use in New York State
Author(s) -
Papadopoulos Eleni A.,
Cummings Karen R.,
Marraffa Jeanna M.,
Aldous Kenneth M.,
Li Lingyun,
Ahmad Nina
Publication year - 2017
Publication title -
the american journal on addictions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.997
H-Index - 76
eISSN - 1521-0391
pISSN - 1055-0496
DOI - 10.1111/ajad.12636
Subject(s) - outbreak , adverse effect , synthetic cannabinoids , medicine , cannabinoid , environmental health , emergency medicine , pharmacology , virology , receptor
Background/Objectives We assessed synthetic cannabinoid (SC) outbreaks from 2011–2012 and 2015. Methods The National Poison Data System was utilized to collect reports of SC adverse effects in New York State from 2011–2012 and 2015 ( N = 713). Results Cases from 2015 were more likely to be admitted to intensive care units and had different symptoms than those in 2011–2012. We identified two new SC structural classes from 2015 samples. Discussion/Conclusions The 2015 outbreak was associated with more severe SC‐related illnesses than in 2011–2012. Scientific Significance New SC compounds may pose a different or more severe risk than those previously identified. (Am J Addict 2017;26:772–775)